Selective Blockade of Oxytocin and Vasopressin V1a Receptors in Anaesthetised Rats: Evidence that Activation of Oxytocin Receptors rather than V1a Receptors Increases Sodium Excretion
Background: Although it is known that moderate-to-high doses of the neurohypophysial hormones oxytocin and vasopressin are natriuretic, doubts remain over the identity of the receptors responsible. To address this issue, we have used highly selective antagonists of oxytocin and vasopressin receptors...
Gespeichert in:
Veröffentlicht in: | Nephron 2011-02, Vol.117 (3), p.p21-p26 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | p26 |
---|---|
container_issue | 3 |
container_start_page | p21 |
container_title | Nephron |
container_volume | 117 |
creator | Shirley, D.G. Walter, M.F. Keeler, B.D. Waters, N.J. Walter, S.J. |
description | Background: Although it is known that moderate-to-high doses of the neurohypophysial hormones oxytocin and vasopressin are natriuretic, doubts remain over the identity of the receptors responsible. To address this issue, we have used highly selective antagonists of oxytocin and vasopressin receptors in animals with elevated endogenous circulating levels of the 2 hormones. Methods: Rats were anaesthetised and prepared surgically for clearance studies, thereby raising plasma oxytocin and vasopressin concentrations. Sodium excretion, glomerular filtration rate and lithium clearance (an index of end-proximal fluid delivery) were measured: first during a control period, then after administration of the selective oxytocin receptor antagonist desGly-NH 2 ,d(CH 2 ) 5 [D-Trp 2 ,Thr 4 ,Dap 5 ]OVT, the selective vasopressin V 1a receptor antagonist d(CH 2 ) 5 [Tyr(Me) 2 ,Dab 5 ]AVP, or vehicle alone. Results: Absolute and fractional sodium excretion fell in rats given the oxytocin antagonist (by 32 and 27%, respectively, compared with corresponding values in vehicle-infused rats), but not in those given the V 1a antagonist or vehicle. Antinatriuresis was associated with a small reduction in the ratio of sodium clearance to lithium clearance (an index of the fraction of distally delivered sodium that escapes reabsorption in the distal nephron). Conclusions: These results corroborate previous studies showing that activation of oxytocin receptors increases sodium excretion and imply that the natriuretic effect of elevated plasma vasopressin concentrations results from stimulation of oxytocin receptors. |
doi_str_mv | 10.1159/000320290 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000320290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2291357851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c192t-c121864fcfa877373fa641e84edf5962e8697dc3db5bc33da575549a0ecc0f1d3</originalsourceid><addsrcrecordid>eNpdkUtPAjEQgBujEUQP3j003jygbfftDQkqCQkJKNfN0M7K8thiWwj8Mv-eJRB8XKYz02--phlCrjm75zzKHhhjgWAiYyekzuOYNQUPktNfeY1cWDtlTIgw5OekJjhLeJbyOvka4hylK9dIn-ZazkAh1QXtb7ZOy7KiUCk6AquXBq319YgDHaDEpdPGUt9oVYDWTdCVFhUdgLOPtLMuFVYSqZuAo62dHlypqz_mH4sBP2928H9_t5IGwaKlQ63K1YJ2Nr6xU12SswLmFq8OZ4O8P3fe2q_NXv-l2271mpJnwvkoeBqHhSwgTZIgCQqIQ45piKqIslhgGmeJkoEaR2MZBAqiJIrCDBhKyQqugga53XuXRn-u_E_zqV6Zyj-Zp1GcMs4E89DdHpJGW2uwyJemXIDZ5pzluw3lxw159mbPzsB8oDmSh-tvK9mNgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>856801020</pqid></control><display><type>article</type><title>Selective Blockade of Oxytocin and Vasopressin V1a Receptors in Anaesthetised Rats: Evidence that Activation of Oxytocin Receptors rather than V1a Receptors Increases Sodium Excretion</title><source>Karger Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Shirley, D.G. ; Walter, M.F. ; Keeler, B.D. ; Waters, N.J. ; Walter, S.J.</creator><creatorcontrib>Shirley, D.G. ; Walter, M.F. ; Keeler, B.D. ; Waters, N.J. ; Walter, S.J.</creatorcontrib><description>Background: Although it is known that moderate-to-high doses of the neurohypophysial hormones oxytocin and vasopressin are natriuretic, doubts remain over the identity of the receptors responsible. To address this issue, we have used highly selective antagonists of oxytocin and vasopressin receptors in animals with elevated endogenous circulating levels of the 2 hormones. Methods: Rats were anaesthetised and prepared surgically for clearance studies, thereby raising plasma oxytocin and vasopressin concentrations. Sodium excretion, glomerular filtration rate and lithium clearance (an index of end-proximal fluid delivery) were measured: first during a control period, then after administration of the selective oxytocin receptor antagonist desGly-NH 2 ,d(CH 2 ) 5 [D-Trp 2 ,Thr 4 ,Dap 5 ]OVT, the selective vasopressin V 1a receptor antagonist d(CH 2 ) 5 [Tyr(Me) 2 ,Dab 5 ]AVP, or vehicle alone. Results: Absolute and fractional sodium excretion fell in rats given the oxytocin antagonist (by 32 and 27%, respectively, compared with corresponding values in vehicle-infused rats), but not in those given the V 1a antagonist or vehicle. Antinatriuresis was associated with a small reduction in the ratio of sodium clearance to lithium clearance (an index of the fraction of distally delivered sodium that escapes reabsorption in the distal nephron). Conclusions: These results corroborate previous studies showing that activation of oxytocin receptors increases sodium excretion and imply that the natriuretic effect of elevated plasma vasopressin concentrations results from stimulation of oxytocin receptors.</description><identifier>ISSN: 1660-2137</identifier><identifier>ISSN: 1660-8151</identifier><identifier>EISSN: 1660-2137</identifier><identifier>EISSN: 2235-3186</identifier><identifier>DOI: 10.1159/000320290</identifier><identifier>PMID: 21071981</identifier><identifier>CODEN: NPRNAY</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Original Paper</subject><ispartof>Nephron, 2011-02, Vol.117 (3), p.p21-p26</ispartof><rights>2010 S. Karger AG, Basel</rights><rights>Copyright (c) 2011 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c192t-c121864fcfa877373fa641e84edf5962e8697dc3db5bc33da575549a0ecc0f1d3</citedby><cites>FETCH-LOGICAL-c192t-c121864fcfa877373fa641e84edf5962e8697dc3db5bc33da575549a0ecc0f1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids></links><search><creatorcontrib>Shirley, D.G.</creatorcontrib><creatorcontrib>Walter, M.F.</creatorcontrib><creatorcontrib>Keeler, B.D.</creatorcontrib><creatorcontrib>Waters, N.J.</creatorcontrib><creatorcontrib>Walter, S.J.</creatorcontrib><title>Selective Blockade of Oxytocin and Vasopressin V1a Receptors in Anaesthetised Rats: Evidence that Activation of Oxytocin Receptors rather than V1a Receptors Increases Sodium Excretion</title><title>Nephron</title><addtitle>Nephron Physiol</addtitle><description>Background: Although it is known that moderate-to-high doses of the neurohypophysial hormones oxytocin and vasopressin are natriuretic, doubts remain over the identity of the receptors responsible. To address this issue, we have used highly selective antagonists of oxytocin and vasopressin receptors in animals with elevated endogenous circulating levels of the 2 hormones. Methods: Rats were anaesthetised and prepared surgically for clearance studies, thereby raising plasma oxytocin and vasopressin concentrations. Sodium excretion, glomerular filtration rate and lithium clearance (an index of end-proximal fluid delivery) were measured: first during a control period, then after administration of the selective oxytocin receptor antagonist desGly-NH 2 ,d(CH 2 ) 5 [D-Trp 2 ,Thr 4 ,Dap 5 ]OVT, the selective vasopressin V 1a receptor antagonist d(CH 2 ) 5 [Tyr(Me) 2 ,Dab 5 ]AVP, or vehicle alone. Results: Absolute and fractional sodium excretion fell in rats given the oxytocin antagonist (by 32 and 27%, respectively, compared with corresponding values in vehicle-infused rats), but not in those given the V 1a antagonist or vehicle. Antinatriuresis was associated with a small reduction in the ratio of sodium clearance to lithium clearance (an index of the fraction of distally delivered sodium that escapes reabsorption in the distal nephron). Conclusions: These results corroborate previous studies showing that activation of oxytocin receptors increases sodium excretion and imply that the natriuretic effect of elevated plasma vasopressin concentrations results from stimulation of oxytocin receptors.</description><subject>Original Paper</subject><issn>1660-2137</issn><issn>1660-8151</issn><issn>1660-2137</issn><issn>2235-3186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkUtPAjEQgBujEUQP3j003jygbfftDQkqCQkJKNfN0M7K8thiWwj8Mv-eJRB8XKYz02--phlCrjm75zzKHhhjgWAiYyekzuOYNQUPktNfeY1cWDtlTIgw5OekJjhLeJbyOvka4hylK9dIn-ZazkAh1QXtb7ZOy7KiUCk6AquXBq319YgDHaDEpdPGUt9oVYDWTdCVFhUdgLOPtLMuFVYSqZuAo62dHlypqz_mH4sBP2928H9_t5IGwaKlQ63K1YJ2Nr6xU12SswLmFq8OZ4O8P3fe2q_NXv-l2271mpJnwvkoeBqHhSwgTZIgCQqIQ45piKqIslhgGmeJkoEaR2MZBAqiJIrCDBhKyQqugga53XuXRn-u_E_zqV6Zyj-Zp1GcMs4E89DdHpJGW2uwyJemXIDZ5pzluw3lxw159mbPzsB8oDmSh-tvK9mNgA</recordid><startdate>201102</startdate><enddate>201102</enddate><creator>Shirley, D.G.</creator><creator>Walter, M.F.</creator><creator>Keeler, B.D.</creator><creator>Waters, N.J.</creator><creator>Walter, S.J.</creator><general>S. Karger AG</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope></search><sort><creationdate>201102</creationdate><title>Selective Blockade of Oxytocin and Vasopressin V1a Receptors in Anaesthetised Rats: Evidence that Activation of Oxytocin Receptors rather than V1a Receptors Increases Sodium Excretion</title><author>Shirley, D.G. ; Walter, M.F. ; Keeler, B.D. ; Waters, N.J. ; Walter, S.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c192t-c121864fcfa877373fa641e84edf5962e8697dc3db5bc33da575549a0ecc0f1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Original Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shirley, D.G.</creatorcontrib><creatorcontrib>Walter, M.F.</creatorcontrib><creatorcontrib>Keeler, B.D.</creatorcontrib><creatorcontrib>Waters, N.J.</creatorcontrib><creatorcontrib>Walter, S.J.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><jtitle>Nephron</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shirley, D.G.</au><au>Walter, M.F.</au><au>Keeler, B.D.</au><au>Waters, N.J.</au><au>Walter, S.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective Blockade of Oxytocin and Vasopressin V1a Receptors in Anaesthetised Rats: Evidence that Activation of Oxytocin Receptors rather than V1a Receptors Increases Sodium Excretion</atitle><jtitle>Nephron</jtitle><addtitle>Nephron Physiol</addtitle><date>2011-02</date><risdate>2011</risdate><volume>117</volume><issue>3</issue><spage>p21</spage><epage>p26</epage><pages>p21-p26</pages><issn>1660-2137</issn><issn>1660-8151</issn><eissn>1660-2137</eissn><eissn>2235-3186</eissn><coden>NPRNAY</coden><abstract>Background: Although it is known that moderate-to-high doses of the neurohypophysial hormones oxytocin and vasopressin are natriuretic, doubts remain over the identity of the receptors responsible. To address this issue, we have used highly selective antagonists of oxytocin and vasopressin receptors in animals with elevated endogenous circulating levels of the 2 hormones. Methods: Rats were anaesthetised and prepared surgically for clearance studies, thereby raising plasma oxytocin and vasopressin concentrations. Sodium excretion, glomerular filtration rate and lithium clearance (an index of end-proximal fluid delivery) were measured: first during a control period, then after administration of the selective oxytocin receptor antagonist desGly-NH 2 ,d(CH 2 ) 5 [D-Trp 2 ,Thr 4 ,Dap 5 ]OVT, the selective vasopressin V 1a receptor antagonist d(CH 2 ) 5 [Tyr(Me) 2 ,Dab 5 ]AVP, or vehicle alone. Results: Absolute and fractional sodium excretion fell in rats given the oxytocin antagonist (by 32 and 27%, respectively, compared with corresponding values in vehicle-infused rats), but not in those given the V 1a antagonist or vehicle. Antinatriuresis was associated with a small reduction in the ratio of sodium clearance to lithium clearance (an index of the fraction of distally delivered sodium that escapes reabsorption in the distal nephron). Conclusions: These results corroborate previous studies showing that activation of oxytocin receptors increases sodium excretion and imply that the natriuretic effect of elevated plasma vasopressin concentrations results from stimulation of oxytocin receptors.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>21071981</pmid><doi>10.1159/000320290</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-2137 |
ispartof | Nephron, 2011-02, Vol.117 (3), p.p21-p26 |
issn | 1660-2137 1660-8151 1660-2137 2235-3186 |
language | eng |
recordid | cdi_crossref_primary_10_1159_000320290 |
source | Karger Journals Complete; Alma/SFX Local Collection |
subjects | Original Paper |
title | Selective Blockade of Oxytocin and Vasopressin V1a Receptors in Anaesthetised Rats: Evidence that Activation of Oxytocin Receptors rather than V1a Receptors Increases Sodium Excretion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A23%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20Blockade%20of%20Oxytocin%20and%20Vasopressin%20V1a%20Receptors%20in%20Anaesthetised%20Rats:%20Evidence%20that%20Activation%20of%20Oxytocin%20Receptors%20rather%20than%20V1a%20Receptors%20Increases%20Sodium%20Excretion&rft.jtitle=Nephron&rft.au=Shirley,%20D.G.&rft.date=2011-02&rft.volume=117&rft.issue=3&rft.spage=p21&rft.epage=p26&rft.pages=p21-p26&rft.issn=1660-2137&rft.eissn=1660-2137&rft.coden=NPRNAY&rft_id=info:doi/10.1159/000320290&rft_dat=%3Cproquest_cross%3E2291357851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=856801020&rft_id=info:pmid/21071981&rfr_iscdi=true |